12:57:04 EST Sun 17 Jan 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Emerald Health Therapeutics Inc
Symbol EMH
Shares Issued 205,471,272
Close 2020-10-30 C$ 0.20
Recent Sedar Documents

Emerald Health prospectus offering

2020-10-30 18:45 ET - Prospectus Approved

The company's short form base shelf prospectus dated March 13, 2019, was filed with and accepted by the TSX Venture Exchange, and filed with and receipted by the British Columbia Securities Commission, pursuant to the provisions of the Securities Act (British Columbia), and the Ontario Securities Commission, pursuant to the provisions of the Securities Act (Ontario), on March 14, 2019. The prospectus was also filed under Multilateral Instrument 11-102, Passport System, in Alberta, Saskatchewan, Manitoba, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador. A receipt for the prospectus is deemed to be issued by the regulators in each of those jurisdictions, if the conditions of the instrument have been satisfied.

Further to an at-the-market offering of shares made pursuant to a prospectus supplement dated Aug. 12, 2020, to the company's short form base shelf prospectus dated March 13, 2019, the TSX Venture Exchange has accepted for filing documentation with respect to the sales set out below under the at-the-market offering. The TSX Venture Exchange has been advised by the company that sales under the at-the-market offering during the month ended Sept. 30, 2020, occurred for gross proceeds of $287,412.45.

Agent:  Eight Capital

Offering:  1,312,500 shares in aggregate during the month ended Sept. 30, 2020

Share price:  varying prices during the month ended Sept. 30, 2020, with an average sale price of 21 cents per share

Agent's warrants:  none

Greenshoe option:  none

Agent's commission:  3 per cent of the gross proceeds of the offering, being $8,622.39 in aggregate for the month ended Sept. 30, 2020

For further information, please refer to the company's short form base shelf prospectus dated March 13, 2019, and prospectus supplement dated Aug. 12, 2020, which are available under the company's SEDAR profile.

© 2021 Canjex Publishing Ltd. All rights reserved.